Vol 78 – Addressing Extractables and Leachables in Drug Development: A Small Biotech Guide
This guide provides a concise overview for small biotech companies on managing Extractables and Leachables during drug development.
Vol 77 – Cracking the Code of Analytical Method Development and Validation in Biosimilars: Unmasking the Hidden Challenges
Unravel the complexities of analytical method development and validation in biosimilars as this enlightening publication exposes the concealed challenges.
Vol 76 – Risk-Based Approaches to Cleaning Validation in CMC Drug Development
This approach optimizes cleaning validation processes in CMC drug development by prioritizing and addressing potential risks associated with drug product cross-contamination.
Vol 73 – Developing a Phase-Appropriate CMC Development Plan for Small Biotechs
Creating a tailored CMC (Chemistry, Manufacturing, and Controls) development roadmap, suitable for the specific phase and needs of small biotechnology companies.
Vol 75 – Trends and Best Practices in Particle Size Analysis for Drug Products
This comprehensive report explores the latest trends and best practices in particle size analysis specifically tailored for drug products.
Vol 74 – Harnessing the Power of Design of Experiments in CMC Drug Development
Utilizing the principles of Design of Experiments to optimize CMC drug development processes and maximize efficiency.
Vol 71 – Unveiling the Art of Developing an Effective Stability Program for Small-Molecule Drug Products
Discover the essential techniques in crafting a successful stability program tailored for small-molecule drug products in this insightful guide.
Vol 70 – Bioprocessing Strategies for Scale-up of Cell Therapies: Insights from a Small Biotech Perspective
This article provides valuable insights into bioprocessing strategies for scaling up cell therapies, offering perspectives from a small biotech company.
Vol 72 – Unmasking the Hidden Threats: A Strategic Guide to Elemental Impurities in Drug Products
“Unmasking the Hidden Threats” is a strategic guide unveiling elemental impurities in drug products, providing essential insights for risk mitigation.
Vol 69: Navigating the Challenges of Bioburden Control in Aseptic Manufacturing
Mastering Bioburden Control: Strategies for Aseptic Manufacturing Success